Earnings Growth and Dividend Increase
Over the past three years, FFO per share grew by 12% and AFFO per share by 19%. The company announced an increase in dividends, supported by earnings growth.
Successful Merger and Asset Sales
The merger with Physicians Realty was highly successful and accretive. Closed $1.3 billion of asset sales at a compelling cap rate of 6.4%, primarily stabilized outpatient medical buildings.
Lab Segment Performance
Year-over-year same-store growth in the lab segment was 5%, exceeding expectations with a positive 11% rent mark-to-market on renewals.
Strong CCRC Portfolio Growth
Year-over-year same-store growth in the CCRC portfolio was 20.8%, driven by better-than-expected occupancy gains and entrance fees.
Strategic Life Science Investments
Announced a $75 million mortgage loan with an 8% interest rate and a purchase option in a strategic location, indicative of targeted investment strategies.